Page last updated: 2024-08-24

fluorodeoxyglucose f18 and cyclin d1

fluorodeoxyglucose f18 has been researched along with cyclin d1 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ebihara, A; Goya, T; Kobayashi, T; Naruke, T; Nomori, H; Ohtsuka, T; Orikasa, H; Uno, K; Watanabe, K; Yamazaki, K1
Fu, Z; Han, A; Mu, D; Sun, X; Yang, W; Yu, J; Zhang, Y1
Honndorf, V; Kukuk, D; Mannheim, JG; Mueller, A; Pichler, BJ; Reischl, G; Röse, L; von Ahsen, O; Wiehr, S1
Meyer, HJ; Surov, A; Wienke, A1

Reviews

1 review(s) available for fluorodeoxyglucose f18 and cyclin d1

ArticleYear
Standardized Uptake Values Derived from
    Contrast media & molecular imaging, 2018, Volume: 2018

    Topics: B7-H1 Antigen; Cyclin D1; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Ki-67 Antigen; Lung Neoplasms; Microvessels; Positron-Emission Tomography; Proliferating Cell Nuclear Antigen; Tumor Suppressor Protein p53

2018

Trials

1 trial(s) available for fluorodeoxyglucose f18 and cyclin d1

ArticleYear
Imaging of proliferation with 18F-FLT PET/CT versus 18F-FDG PET/CT in non-small-cell lung cancer.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cyclin D1; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed

2010

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and cyclin d1

ArticleYear
[F-18]Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas.
    Japanese journal of clinical oncology, 2006, Volume: 36, Issue:7

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Cell Proliferation; Cyclin D1; Female; Fluorodeoxyglucose F18; Genes, Tumor Suppressor; Humans; Ki-67 Antigen; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Tumor Suppressor Protein p53

2006
Preclinical evaluation of a novel c-Met inhibitor in a gastric cancer xenograft model using small animal PET.
    Molecular imaging and biology, 2013, Volume: 15, Issue:2

    Topics: Analysis of Variance; Animals; Antineoplastic Agents; Cyclin D1; Extracellular Signal-Regulated MAP Kinases; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-met; Stomach Neoplasms; Xenograft Model Antitumor Assays

2013